Richie K Plus 50mg/500mg/10mg Tablet
By Richie K Plus
Rx
10 Tablet in a Strip

Composition
Diclofenac(50mg) + Paracetamol(500mg) + Serratiopeptidase(10mg)

Manufacturer - Richie Laboratories Ltd
5, Devkaran Mansion, 24, Mangaldas Road, Kalbadevi, Mumbai-400002.

Expires on or after
October, 2025

liver
When using Richie K Plus 50mg/500mg/10mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments to their dosage of Richie K Plus 50mg/500mg/10mg Tablet, so it is essential to consult with your doctor before taking this medication. It is advised not to use Richie K Plus 50mg/500mg/10mg Tablet if you have severe liver disease or active liver disease. Consulting a healthcare professional is crucial to ensure the safe use of Richie K Plus 50mg/500mg/10mg Tablet in relation to liver health.

kidney
Richie K Plus 50mg/500mg/10mg Tablet may need dose adjustment in patients with kidney disease. Consult your doctor for proper guidance.

alcohol
It is not safe to drink alcohol while taking Richie K Plus 50mg/500mg/10mg Tablet. Combining alcohol with the tablet can be harmful.

driving
When taking Richie K Plus 50mg/500mg/10mg Tablet, be cautious as it may cause side effects such as headaches, blurred vision, dizziness, or drowsiness. These effects can impact your ability to drive safely.

pregnancy
Richie K Plus 50mg/500mg/10mg Tablet is not safe to use during pregnancy due to potential risks to the developing baby. However, in rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before using.

breastfeeding
Information regarding the use of Richie K Plus 50mg/500mg/10mg Tablet during breastfeeding is not available. It is better to consult your doctor before using Richie K Plus 50mg/500mg/10mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹37
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025